Yan Zeng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yan Zeng has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
- Chunfeng Wang
College of Veterinary Medicine, Jilin Agricultural University, Changchun, China
25 shared publications - Xin Cao
College of Veterinary Medicine, Jilin Agricultural University, Changchun, China
25 shared publications Yiyuan Lu
College of Veterinary Medicine, Jilin Agricultural University, Changchun, China
15 shared publicationsWentao Yang
College of Veterinary Medicine, Jilin Agricultural University, Changchun, China
14 shared publicationsYanlong Jiang
College of Veterinary Medicine, Jilin Agricultural University, Changchun, China
14 shared publicationsChunwei Shi
College of Veterinary Medicine, Jilin Agricultural University, Changchun, China
13 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Springer Nature in npj Biofilms and Microbiomes
C19orf18 modulates host susceptibility to Salmonella Typhimurium infection via remodeling of the gut microbiota and tryptophan metabolism
- 21 October 2026
- Published by Springer Nature in npj Biofilms and Microbiomes
Open AccessC19orf18 modulates host susceptibility to Salmonella Typhimurium infection via remodeling of the gut microbiota and tryptophan metabolism
- Open Access
- 13 October 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (12)
ATG13 recruits LC3 to target H9N2-IAV PB1 for autophagic-lysosomal degradation and restricts viral replication
- 13 October 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (12)
Open AccessATG13 recruits LC3 to target H9N2-IAV PB1 for autophagic-lysosomal degradation and restricts viral replication
- Open Access
- 16 September 2026
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 15 (1)
ATG13 promotes K63-linked polyubiquitination of MAVS via ASB1 to restrict influenza A virus replication
The innate immune system constitutes the host's primary defense against viral infection through the use of specific pattern recognition receptors (PRRs) for different viruses, which activate interf...
- 16 September 2026
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 15 (1)
Open AccessATG13 promotes K63-linked polyubiquitination of MAVS via ASB1 to restrict influenza A virus replication
The innate immune system constitutes the host's primary defense against viral infection through the use of specific pattern recognition receptors (PRRs) for different viruses, which activate interf...
- Open Access
- 20 May 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (5) , 1155
Protective Effect of Escherichia coli Nissle 1917 on Salmonella typhimurium Infection by Regulating Intestinal Flora
Salmonellosis is a global foodborne pathogen with zoonotic importance that seriously threatens livestock breeding and human health. Due to the implementation of an anti-resistance policy, probiotics as an alternative to antibiotics have attracted widespread attention. In this study, the widely used probiotic Escherichia coli Nissle 1917 (EcN) was selected to study its protective effect on mice infected with Salmonella typhimurium. Two mice groups (n = 15) were treated with either EcN and PBS. Flow cytometry showed that the frequency of mature dendritic cells in the Peyer’s patch was significantly increased compared to the PBS group. Previous administration of EcN protected against challenge with Salmonella typhimurium infection as an increased survival rate of the mice, a decreased degree of pathological changes, and the number of live bacteria in the spleen and liver were recorded compared to the control group. The results of 16S rRNA high-throughput sequencing of fecal microbial flora showed that EcN could reduce the abundance of microorganisms in the intestine and reduce the proportion of Lactobacillus, while Ruminococcaceae sp., Rikenella sp. and Bifidobacterium sp. disappeared. In contrast, the abundance of Bacteroides increased, which reduced the effect of Salmonella typhimurium on the distribution of intestinal microorganisms. Our results demonstrated that EcN has a protective effect against Salmonella typhimurium infection and may act as a candidate probiotic bacterium to apply in the future.
- 20 May 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (5) , 1155
Open AccessProtective Effect of Escherichia coli Nissle 1917 on Salmonella typhimurium Infection by Regulating Intestinal Flora
Salmonellosis is a global foodborne pathogen with zoonotic importance that seriously threatens livestock breeding and human health. Due to the implementation of an anti-resistance policy, probiotics as an alternative to antibiotics have attracted widespread attention. In this study, the widely used probiotic Escherichia coli Nissle 1917 (EcN) was selected to study its protective effect on mice infected with Salmonella typhimurium. Two mice groups (n = 15) were treated with either EcN and PBS. Flow cytometry showed that the frequency of mature dendritic cells in the Peyer’s patch was significantly increased compared to the PBS group. Previous administration of EcN protected against challenge with Salmonella typhimurium infection as an increased survival rate of the mice, a decreased degree of pathological changes, and the number of live bacteria in the spleen and liver were recorded compared to the control group. The results of 16S rRNA high-throughput sequencing of fecal microbial flora showed that EcN could reduce the abundance of microorganisms in the intestine and reduce the proportion of Lactobacillus, while Ruminococcaceae sp., Rikenella sp. and Bifidobacterium sp. disappeared. In contrast, the abundance of Bacteroides increased, which reduced the effect of Salmonella typhimurium on the distribution of intestinal microorganisms. Our results demonstrated that EcN has a protective effect against Salmonella typhimurium infection and may act as a candidate probiotic bacterium to apply in the future.
- 1 May 2026
- Published by Elsevier in Microbial Pathogenesis
- Vol. 216, 108526
Autophagy induced by Trichinella spiralis infection alleviate TNBS-induced colitis in mice through inhibiting the NLRP3 inflammasome
- 1 May 2026
- Published by Elsevier in Microbial Pathogenesis
- Vol. 216, 108526
Autophagy induced by Trichinella spiralis infection alleviate TNBS-induced colitis in mice through inhibiting the NLRP3 inflammasome
- Open Access
- 1 January 2026
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2026 (1) , e5789277
Porcine Rotavirus NSP4 Inhibits Type I Interferon Production via NRBF2‐Mediated Autophagic Degradation of MDA‐5
The type I interferon (IFN‐I) signaling pathway plays a pivotal role in orchestrating antiviral innate immune defenses, particularly during the clearance of invading pathogens. Rotaviruses have evolved a repertoire of viral proteins to counteract host immune surveillance. While certain functions of rotavirus nonstructural proteins in antagonizing IFN‐I signaling have been characterized, the precise molecular mechanism by which nonstructural protein 4 (NSP4) impairs host immunity remains elusive. Here, we demonstrated that the porcine rotavirus (PoRV) nonstructural protein NSP4 potently suppresses the transcriptional activation of interferon‐stimulated genes (ISGs), IFN‐β promoters, and interferon‐sensitive response elements (ISREs) while abrogating the phosphorylation of interferon regulatory factor 3 (IRF3). Mechanistically, NSP4 promotes the degradation of melanoma differentiation‐associated gene 5 (MDA‐5) via nuclear receptor binding factor 2 (NRBF2)‐dependent autophagy, thereby subverting IFN‐I production. The validity of this mechanism in primary epithelial cells was also verified by constructing an intestinal organoid model in piglets. Collectively, our findings elucidate a previously unrecognized immune evasion mechanism by which NSP4 antagonizes the IFN‐I‐mediated antiviral response, providing novel molecular insights for developing therapeutic strategies against rotavirus infections.
- 1 January 2026
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2026 (1) , e5789277
Open AccessPorcine Rotavirus NSP4 Inhibits Type I Interferon Production via NRBF2‐Mediated Autophagic Degradation of MDA‐5
The type I interferon (IFN‐I) signaling pathway plays a pivotal role in orchestrating antiviral innate immune defenses, particularly during the clearance of invading pathogens. Rotaviruses have evolved a repertoire of viral proteins to counteract host immune surveillance. While certain functions of rotavirus nonstructural proteins in antagonizing IFN‐I signaling have been characterized, the precise molecular mechanism by which nonstructural protein 4 (NSP4) impairs host immunity remains elusive. Here, we demonstrated that the porcine rotavirus (PoRV) nonstructural protein NSP4 potently suppresses the transcriptional activation of interferon‐stimulated genes (ISGs), IFN‐β promoters, and interferon‐sensitive response elements (ISREs) while abrogating the phosphorylation of interferon regulatory factor 3 (IRF3). Mechanistically, NSP4 promotes the degradation of melanoma differentiation‐associated gene 5 (MDA‐5) via nuclear receptor binding factor 2 (NRBF2)‐dependent autophagy, thereby subverting IFN‐I production. The validity of this mechanism in primary epithelial cells was also verified by constructing an intestinal organoid model in piglets. Collectively, our findings elucidate a previously unrecognized immune evasion mechanism by which NSP4 antagonizes the IFN‐I‐mediated antiviral response, providing novel molecular insights for developing therapeutic strategies against rotavirus infections.
- Open Access
- 6 November 2025
- Published by Springer Nature in Research Square
Adjuvant-induced macrophage activation compromises BA71ΔCD2-mediated protection against African swine fever virus
While the development of effective subunit vaccines against African swine fever (ASF) is ongoing, live attenuated vaccines (LAVs) remain the only current strategy capable of inducing robust protective immunity. However, potential biosafety concerns limit their implementation in the field. Thus, further research is required to develop optimized LAVs with better biosafety profiles. Both the ASF virus (ASFV) and derived LAVs suppress innate immune responses of macrophages, thereby limiting their contribution to the induction of protective immune responses. We hypothesized that adjuvants could restore the functionality of LAV-infected macrophages, allowing for a reduction in the vaccine’s effective dose and consequently minimizing the risk of adverse events. To test this hypothesis, we intranasally vaccinated pigs with a suboptimal dose of the LAV BA71ΔCD2, either alone or in combination with two adjuvants derived from the immunostimulatory bacterium Rothia nasimurium . The two immunostimulants enhanced the responsiveness of BA71ΔCD2-infected macrophages, which acquired features of antigen presenting cells. However, both adjuvants reduced the levels of ASFV-specific humoral and cellular responses induced by BA71ΔCD2, consequently decreasing the level of protection against a lethal challenge. Further in vitro analyses demonstrated that adjuvant-activated macrophages acquired an antiviral state, thereby reducing the replication capability of the LAV. Thus, the adjuvant-mediated decline in vaccine efficacy might result from a lower antigen production by infected cells. These results demonstrate that the use of adjuvants combined with ASFV-based LAVs will require a fine-tune manipulation of macrophages, enhancing their functionality while avoiding a significant inhibition of virus replication, reaching the required balance between the levels of viral antigens and innate immune responses to trigger a protective adaptive immunity.
- 6 November 2025
- Published by Springer Nature in Research Square
Open AccessAdjuvant-induced macrophage activation compromises BA71ΔCD2-mediated protection against African swine fever virus
While the development of effective subunit vaccines against African swine fever (ASF) is ongoing, live attenuated vaccines (LAVs) remain the only current strategy capable of inducing robust protective immunity. However, potential biosafety concerns limit their implementation in the field. Thus, further research is required to develop optimized LAVs with better biosafety profiles. Both the ASF virus (ASFV) and derived LAVs suppress innate immune responses of macrophages, thereby limiting their contribution to the induction of protective immune responses. We hypothesized that adjuvants could restore the functionality of LAV-infected macrophages, allowing for a reduction in the vaccine’s effective dose and consequently minimizing the risk of adverse events. To test this hypothesis, we intranasally vaccinated pigs with a suboptimal dose of the LAV BA71ΔCD2, either alone or in combination with two adjuvants derived from the immunostimulatory bacterium Rothia nasimurium . The two immunostimulants enhanced the responsiveness of BA71ΔCD2-infected macrophages, which acquired features of antigen presenting cells. However, both adjuvants reduced the levels of ASFV-specific humoral and cellular responses induced by BA71ΔCD2, consequently decreasing the level of protection against a lethal challenge. Further in vitro analyses demonstrated that adjuvant-activated macrophages acquired an antiviral state, thereby reducing the replication capability of the LAV. Thus, the adjuvant-mediated decline in vaccine efficacy might result from a lower antigen production by infected cells. These results demonstrate that the use of adjuvants combined with ASFV-based LAVs will require a fine-tune manipulation of macrophages, enhancing their functionality while avoiding a significant inhibition of virus replication, reaching the required balance between the levels of viral antigens and innate immune responses to trigger a protective adaptive immunity.
- Open Access
- 3 March 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (5) , 2257
Lactobacillus plantae Expressing Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Single-Chain Antibody Can Inhibit PRRSV Replication and Change the Intestinal Flora Structure of Piglets
Porcine reproductive and respiratory syndrome (PRRS) is an infectious disease that can cause reproductive disorders in sows and affect the breathing of piglets, seriously endangering pig breeding worldwide. In this study, Lactobacillus plantarum NC8 was used as the expression delivery vector of foreign proteins, and a single-chain antibody was designed based on an mAb-PN9cx3 sequence. Three recombinant strains of Lactobacillus plantarum, namely, NC8/pSIP409-pgsA‘-PN9cx3-scFV(E), NC8/pSIP409-pgsA’-PN9cx3-HC(E), and NC8/pSIP409-pgsA‘-PN9cx3-LC(E), were successfully constructed. In an in vitro test, the viral load of each experimental group was significantly lower than that of the control group (p < 0.01). In the piglet challenge protection test, the percentage of CD3+CD8+T cells in the blood of piglets given complex lactic acid bacteria was significantly increased before and after the challenge (p < 0.01); the body temperature of piglets in this group was normal, the viral load of each organ was reduced, and the obvious pathological changes in each tissue were alleviated. At the same time, the abundance of Bacteroides, Fusobacterium, and other bacteria in the intestinal tracts of the piglets changed, affecting the metabolism of carbohydrates and amino acids and the differentiation of Th1 and Th2 cells. This experiment provides a feasible strategy and method for the design of a PRRSV vaccine.
- 3 March 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (5) , 2257
Open AccessLactobacillus plantae Expressing Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Single-Chain Antibody Can Inhibit PRRSV Replication and Change the Intestinal Flora Structure of Piglets
Porcine reproductive and respiratory syndrome (PRRS) is an infectious disease that can cause reproductive disorders in sows and affect the breathing of piglets, seriously endangering pig breeding worldwide. In this study, Lactobacillus plantarum NC8 was used as the expression delivery vector of foreign proteins, and a single-chain antibody was designed based on an mAb-PN9cx3 sequence. Three recombinant strains of Lactobacillus plantarum, namely, NC8/pSIP409-pgsA‘-PN9cx3-scFV(E), NC8/pSIP409-pgsA’-PN9cx3-HC(E), and NC8/pSIP409-pgsA‘-PN9cx3-LC(E), were successfully constructed. In an in vitro test, the viral load of each experimental group was significantly lower than that of the control group (p < 0.01). In the piglet challenge protection test, the percentage of CD3+CD8+T cells in the blood of piglets given complex lactic acid bacteria was significantly increased before and after the challenge (p < 0.01); the body temperature of piglets in this group was normal, the viral load of each organ was reduced, and the obvious pathological changes in each tissue were alleviated. At the same time, the abundance of Bacteroides, Fusobacterium, and other bacteria in the intestinal tracts of the piglets changed, affecting the metabolism of carbohydrates and amino acids and the differentiation of Th1 and Th2 cells. This experiment provides a feasible strategy and method for the design of a PRRSV vaccine.
- 24 December 2024
- Published by Elsevier in Veterinary Parasitology
- Vol. 334, 110386
Interleukin-13 partly induced by the NLRP3 inflammasome promotes Trichinella spiralis encapsulation in infected mice
- 24 December 2024
- Published by Elsevier in Veterinary Parasitology
- Vol. 334, 110386
Interleukin-13 partly induced by the NLRP3 inflammasome promotes Trichinella spiralis encapsulation in infected mice
- Open Access
- 4 December 2024
- Published by Elsevier in Poultry Science
- Vol. 104 (1) , 104639
The PB1 protein of H9N2 influenza A virus inhibits antiviral innate immunity by targeting MAVS for TRIM25-mediated autophagic degradation
- 4 December 2024
- Published by Elsevier in Poultry Science
- Vol. 104 (1) , 104639
Open AccessThe PB1 protein of H9N2 influenza A virus inhibits antiviral innate immunity by targeting MAVS for TRIM25-mediated autophagic degradation